Completed PHASE4 INTERVENTIONAL 2-arm
NCT02090400
Switching From Oral Bisphosphonates to Bazedoxifene to Evaluate Effects on Bone Mineral Density in Postmenopausal Women
Multi-centre, Randomized, Open Label Trial to Evaluate the Effects of Switching to Bazedoxifene in Comparison With Switching to Calcium and Vitamin D in Postmenopausal Women Previously Treated With Bisphosphonates
Sponsor: Instituto Palacios
Conditions
Osteoporosis, Postmenopausal
Interventions
Bazedoxifene Calcium/Vit D
Last updated: Sep 8, 2015 Started: May 31, 2013 Primary completion: Jul 31, 2015 Completion: Jul 31, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE4 trial investigates Osteoporosis, Postmenopausal and is currently completed. Instituto Palacios leads this study, which shows 0 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Change History
No change history available.
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Instituto Palacios
- Pfizer
Data source: Instituto Palacios
For direct contact, visit the study record on ClinicalTrials.gov .